Microbix Biosystems Inc. MBX.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1,387.10% | -466.66% | -321.07% | -163.20% | -106.34% |
| Total Depreciation and Amortization | 15.76% | 15.03% | 11.32% | 15.13% | 10.01% |
| Total Amortization of Deferred Charges | -50.73% | -50.73% | -50.73% | -75.22% | -1.64% |
| Total Other Non-Cash Items | 9.83% | 28.05% | 17.05% | 12.49% | 151.90% |
| Change in Net Operating Assets | 21.92% | -717.02% | -180.83% | 59.76% | 23.51% |
| Cash from Operations | -650.43% | -220.18% | -190.18% | -102.21% | -72.19% |
| Capital Expenditure | 31.02% | 47.30% | 58.70% | 52.74% | 44.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Investing | 31.02% | 55.86% | 64.07% | 59.41% | 52.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.52% | 82.29% | -325.20% | -325.98% | -326.86% |
| Issuance of Common Stock | -100.00% | -100.00% | 517.23% | 674.16% | 690.06% |
| Repurchase of Common Stock | 57.61% | 51.75% | -0.65% | -87.03% | -130.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.02% | 34.15% | 65.04% | 29.74% | -31.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -225.89% | -842.81% | -1,866.08% | -220.01% | -137.90% |